BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15727558)

  • 1. Application of sterylglucoside-containing particles for drug delivery.
    Maitani Y; Nakamura K; Kawano K
    Curr Pharm Biotechnol; 2005 Feb; 6(1):81-93. PubMed ID: 15727558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biodistribution and hepatocytes targeting of cationic liposomes surface-modified with sterylglucoside and golyethylene glycol].
    Shi J; Yan WW; Qi XR; Yang L; Zhang L
    Yao Xue Xue Bao; 2004 Jul; 39(7):551-5. PubMed ID: 15493849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liver targeting of cationic liposomes modified with soybean-derived sterylglucoside in vitro].
    Shi J; Qi XR; Yang L; Fei R; Wei L
    Yao Xue Xue Bao; 2006 Jan; 41(1):19-23. PubMed ID: 16683522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and biodistribution of soybean sterylglucoside and polyethylene glycol-modified cationic liposomes and their complexes with antisense oligodeoxynucleotide.
    Shi J; Yan WW; Qi XR; Maitani Y; Nagai T
    Drug Deliv; 2005; 12(6):349-56. PubMed ID: 16253950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol.
    Qi XR; Yan WW; Shi J
    World J Gastroenterol; 2005 Aug; 11(32):4947-52. PubMed ID: 16124043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits.
    Muramatsu K; Maitani Y; Takayama K; Nagai T
    Drug Dev Ind Pharm; 1999 Oct; 25(10):1099-105. PubMed ID: 10529890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells.
    Maitani Y; Kawano K; Yamada K; Nagai T; Takayama K
    J Control Release; 2001 Aug; 75(3):381-9. PubMed ID: 11489324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability and antitumor effects of all-trans retinoic acid-loaded liposomes contained sterylglucoside mixture.
    Shimizu K; Tamagawa K; Takahashi N; Takayama K; Maitani Y
    Int J Pharm; 2003 Jun; 258(1-2):45-53. PubMed ID: 12753752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enhancing effect of soybean-derived sterylglucoside and beta-sitosterol beta-D-glucoside on nasal absorption in rabbits.
    Maitani Y; Nakamura K; Suenaga H; Kamata K; Takayama K; Nagai T
    Int J Pharm; 2000 Apr; 200(1):17-26. PubMed ID: 10845682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation of liposomes with a soybean-derived sterylglucoside mixture and cholesterol for liver targeting.
    Shimizu K; Maitani Y; Takayama K; Nagai T
    Biol Pharm Bull; 1997 Aug; 20(8):881-6. PubMed ID: 9300135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of soybean-derived sterylglucoside liposomes to liver tumors in rat and mouse models.
    Shimizu K; Qi XR; Maitani Y; Yoshii M; Kawano K; Takayama K; Nagai T
    Biol Pharm Bull; 1998 Jul; 21(7):741-6. PubMed ID: 9703260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery.
    Mainardes RM; Urban MC; Cinto PO; Chaud MV; Evangelista RC; GremiĆ£o MP
    Curr Drug Deliv; 2006 Jul; 3(3):275-85. PubMed ID: 16848729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of liposomes containing a soybean-derived sterylglucoside mixture with rat primary cultured hepatocytes.
    Shimizu K; Maitani Y; Takahashi N; Takayama K; Nagai T
    Biol Pharm Bull; 1998 Aug; 21(8):818-22. PubMed ID: 9743249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physico-chemical characterization and application for drug carrier of soybean-derived sterols and their glucosides-containing liposomes].
    Maitani Y
    Yakugaku Zasshi; 1996 Dec; 116(12):901-10. PubMed ID: 8993229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
    Rudokas M; Najlah M; Alhnan MA; Elhissi A
    Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembled mirror DNA nanostructures for tumor-specific delivery of anticancer drugs.
    Kim KR; Kim HY; Lee YD; Ha JS; Kang JH; Jeong H; Bang D; Ko YT; Kim S; Lee H; Ahn DR
    J Control Release; 2016 Dec; 243():121-131. PubMed ID: 27746274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nanostructured liposomal systems as transport agents for anticancer drugs].
    Baryshnikov AIu
    Vestn Ross Akad Med Nauk; 2012; (3):23-31. PubMed ID: 22712271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on M5076-hepatic metastasis of retinoic acid and N-(4-hydroxyphenyl) retinamide, fenretinide entrapped in SG-liposomes.
    Takahashi N; Tamagawa K; Shimizu K; Fukui T; Maitani Y
    Biol Pharm Bull; 2003 Jul; 26(7):1060-3. PubMed ID: 12843642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of sterylglucoside-modified liposomes for levonorgestrel delivery via nasal route.
    Ding WX; Qi XR; Fu Q; Piao HS
    Drug Deliv; 2007 Feb; 14(2):101-4. PubMed ID: 17364874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand peptide-grafted PEGylated liposomes using HER2 targeted peptide-lipid derivatives for targeted delivery in breast cancer cells: The effect of serine-glycine repeated peptides as a spacer.
    Suga T; Fuchigami Y; Hagimori M; Kawakami S
    Int J Pharm; 2017 Apr; 521(1-2):361-364. PubMed ID: 28237886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.